Non-toxic Recombinant Ebov (subtype Zaire, Strain Mayinga 1976) Gp-rbd / Glycoprotein Protein (his Tag) [limited Qty] [Wuja6Ik3]
Recombinant EBOV GP-RBD Protein: A Game-Changer in Viral ResearchRecombinant Ebola virus (EBOV) GP-RBD protein, sourced from the Mayinga strain of the Zaire subtype, represents a significant advancement in the field of virology. This highly purified
Secure Shopping
100% Safe Guarantee
Free Shipping
On orders over $30
Money-Back
30-Day Guarantee
Non-toxic Recombinant Ebov (subtype Zaire, Strain Mayinga 1976) Gp-rbd / Glycoprotein Protein (his Tag) [limited Qty] [Wuja6Ik3]
Recombinant EBOV GP-RBD Protein: A Game-Changer in Viral Research
Recombinant Ebola virus (EBOV) GP-RBD protein, sourced from the Mayinga strain of the Zaire subtype, represents a significant advancement in the field of virology. This highly purified protein, derived from HEK293 cells, serves as a valuable tool for researchers studying the Ebola virus and its entry mechanisms. The GP-RBD, which stands for the Glycoprotein Receptor-Binding Domain, plays a critical role in the virus's interaction with host cells, making it a key target for vaccine development and antiviral therapy. The following features make this recombinant protein a sought-after product in research labs:
- High Purity: The protein is >95% pure, ensuring reliable and consistent results in experiments.
- Expression Host: The protein is produced in HEK293 cells, which provide a robust and reliable expression system.
- Sequence and Accession: The protein is sequenced from Met1 to Phe308 and has an accession number of AAC54887.1.
Unveiling the Potential of Recombinant EBOV GP-RBD Protein
The Recombinant EBOV GP-RBD protein is a powerful tool for investigating the complex biology of the Ebola virus. Its unique features make it ideal for various applications, including:
- Antiviral Drug Discovery: The GP-RBD protein can be used to identify and test potential antiviral drugs that can inhibit the virus's entry into host cells.
- Immunology Studies: It serves as a valuable antigen for generating antibodies against the Ebola virus, aiding in the development of diagnostic tests and vaccines.
- Structural Biology: The protein can be crystallized to study the structure of the GP-RBD and its interactions with host cell receptors.
With its high purity, specific sequence, and proven bioactivity, the Recombinant EBOV GP-RBD protein is a reliable and versatile reagent for researchers in virology, immunology, and structural biology. Its availability as a lyophilized powder ensures convenient storage and long-term stability. By using this product, researchers can unlock the secrets of the Ebola virus and contribute to the development of effective treatments and preventive measures against this deadly pathogen.
What Our Customers Say
Absolutely no complaints!
A very reliable and exceptionally well-made product.
- Clive D..
Absolutely no complaints!
A solid buy that I am very, very happy to endorse.
- Kermit G..
Absolutely no complaints!
This has made a significant and positive impact.
- Zebadiah Z..